
About
This app assists with adjusting intravenous drip rates on Apple Watch. It allows for quick adjustments of flow rate and displays drops per minute and seconds per drop. Visual, auditory, and haptic feedback support the tempo.
What's New in TekikaAwase
1.0
May 31, 2026
User reviews
Developer apps
FAQ
What is TekikaAwase?
TekikaAwase is a simple auxiliary app designed for Apple Watch to intuitively check and adjust intravenous drip rates. It helps users quickly set flow rates and provides visual, auditory, and haptic feedback for tempo support.
How does TekikaAwase adjust drip rates?
You can quickly adjust the flow rate in 10mL/h increments using the Apple Watch crown. The app supports both 20 drops/mL and 60 drops/mL drip sets, automatically calculating the drops per minute and displaying the seconds per drop in real-time.
Can TekikaAwase be used without an iPhone?
Yes, TekikaAwase can be used independently on an Apple Watch. This allows for quick and direct adjustments and monitoring without needing to access your iPhone.
What kind of feedback does TekikaAwase provide?
TekikaAwase offers multiple feedback options to support the drip tempo. This includes visual feedback via a ripple animation, auditory cues that can be turned on or off, and haptic vibrations that can also be toggled.
Is TekikaAwase a medical device?
No, TekikaAwase is not a medical device. The app is intended as an auxiliary tool, and actual administration management should always follow the judgment of medical professionals and facility standards.
What is the price of TekikaAwase?
TekikaAwase is a paid application, available for $1.99. This one-time purchase grants access to all its features.
What devices support TekikaAwase?
TekikaAwase is designed to work on Apple Watch, iPhone, and iPad. Its primary functionality is optimized for the Apple Watch for on-the-go use.
When was TekikaAwase last updated?
TekikaAwase was last updated on May 31, 2026, with version 1.0. The app was also released on this date, indicating it is a new application.



